Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology/Urology
Disease Category: Benign Prostatic Hyperplasia (Enlarged Prostate)
Trial Information
Benign Prostatic Hypertrophy (BPH)
Study to evaluate the safety and efficacy of a medication in patients with lower urinary symptoms (LUTS) due to benign prostatic hypertrophy (BPH)
Patient Inclusion Criteria:
- Men 50 years of age with a diagnosis of BPH and clinical signs and symptoms of BPH greater than 6 months
- PSA greater than 0.8ng/ml between 4 and 10
- Must have biopsy to rule out cancer
Patient Exclusion Criteria:
- History of prostate cancer or PSA greater than 10
- Prior prostate or bladder surgery, pelvic surgery, pelvic radiation
- Taking testosterone, Class IA, or Class II antiarrhythmic medications
- 5 ARI medications
- Alpha blockers (6 week wash out)
- History of Urethral Stricture, bladder stones or neurogenic bladder
- Urinary Retention
Cheryl Ahlstrom, Patient Liasion
South Florida Medical Research
21150 Biscayne Blvd., Suite 300
Aventura, FL 33180
Phone: 305-931-8080 Extension 21
Fax: 305-931-8088
EMail: Info@southfloridamedicalresearch.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
